Preventive effects of Hangeshashinto for oral mucositis in Hematopoietic Stem Cell Transplantation Recipients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs071200012

Enrollment

Registered

2020-05-07

Start date

2020-07-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who will undergo allogeneic hematopoietic stem cell transplantation

Interventions

Gargling with Hangeshashinto

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will undergo allogeneic hematopoietic stem cell transplantation

Exclusion criteria

Exclusion criteria: Patients with problem in judgement

Design outcomes

Primary

Measure	Time frame
Incidence and onset timing of grade 2 oral mucositis	—

Secondary

Measure	Time frame
Incidence and onset timing of grade 1,3,4 and 5 oral mucositis	—

Contacts

Public ContactMasako Yoshimatsu

Nagasaki University Hospital

yoshi@nagasaki-u.ac.jp+81-958197663

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026